Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuronNov 25, 2020
The draft Commission implementing regulation approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10Nov 25, 2020
Strengthening Media Freedom: the Protection of Journalists in Europe, Hate Speech, Disinformation and the Role of PlatformsNov 25, 2020
Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”)Nov 13, 2020
EU/Seychelles Sustainable Fisheries Partnership Agreement and Implementing Protocol (2020-2026)SeychellesNov 12, 2020
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87427 × MON 89034 × MIR162 × NK603 and genetically modified maize combining two or three of the single events MON 87427, MON 89034, MIR162 and NK603, and repealing Commission Implementing Decision (EU) 2018/1111 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the CouncilNov 11, 2020
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean SYHT0H2 (SYN-ØØØH2-5), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the CouncilNov 11, 2020